GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Price-to-Owner-Earnings

Curocell (XKRX:372320) Price-to-Owner-Earnings : (As of Jun. 05, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Price-to-Owner-Earnings?

As of today (2024-06-05), Curocell's share price is ₩31600.00. Curocell does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Curocell's Price-to-Owner-Earnings or its related term are showing as below:


XKRX:372320's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 33.78
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-06-05), Curocell's share price is ₩31600.00. Curocell does not have enough years/quarters to calculate the Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023. Therefore GuruFocus does not calculate PE Ratio at this moment.

As of today (2024-06-05), Curocell's share price is ₩31600.00. Curocell does not have enough years/quarters to calculate the EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2023. Therefore GuruFocus does not calculate PE Ratio without NRI at this moment.


Curocell Price-to-Owner-Earnings Historical Data

The historical data trend for Curocell's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Price-to-Owner-Earnings Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
- - - - -

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings - - - -

Competitive Comparison of Curocell's Price-to-Owner-Earnings

For the Biotechnology subindustry, Curocell's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curocell's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Curocell's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Curocell's Price-to-Owner-Earnings falls into.



Curocell Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Curocell's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=31600.00/-3242.41
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curocell  (XKRX:372320) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Curocell Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Curocell's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines